We thank our sponsors:

GOLDSPONSORS

PLATINUMSPONSOR

Agenda Location: Hotel Sofitel, Salon Pablo Picasso 1155 Sherbrooke West, Montreal, Quebec H3A 2N3, Canada From 11.30am onwards: Registration and light lunch

3.45pm Coffee Break

12.30pm

12.45pm

13.30pm

2:15pm

3:00pm

Welcome Address Hubert Birner, Managing Partner, TVM Capital Life Science Speaker: Marc de Garidel – Chairman, IPSEN Introduction by Vanessa Grant, Norton Rose Fulbright Speaker: Andrew Dahlem, Vice President, COO, Lilly Research Laboratories/LRL Europe Moderator and introduction: Daniel Parera, Executive-in-Residence, TVM Capital Life Science Panel #1: New Models in Venture Capital Peter van der Velden – Managing General Partner, Lumira Capital Jean-Francois Leprince – Managing Partner, CtI Life Sciences Barbara Dalton – Vice President Venture Capital, Pfizer Didier Leconte – Senior Investment Director, Fonds de solidarité FTQ David Hirsch - Managing Director and Founder, Longitude Capital Moderator and introduction: Luc Marengere, Managing Partner, TVM Capital Life Science New deals: Arndt Rolfs – CEO and founder, Centogene, Berlin Gabriel Robichaud – President and co-founder, Panthera Dental, Quebec City

We thank our sponsors:

GOLDSPONSORS

PLATINUMSPONSOR

4.15pm

5.00pm

5:45pm

Panel #2: Orphan Drugs & Rare Diseases Clarissa Desjardins – CEO, Clementia Pharmaceuticals Angela Genge – Medical Director, Clinical Research Unit and ALS Clinic, Neurological Institute and Hospital Robert Steiner - Chief Medical Officer, Acer Therapeutics Stacy Coen - Head of Rare Disease Business Development and Licensing, Sanofi Moderator and introduction: Marc Rivière, General Partner, TVM Capital Life Science “Macro Economic Speaker” Nils Behnke - Director, Bain & Company, Moderator and Introduction Hubert Birner, Managing Partner, TVM Capital Life Science Wrap up and Outlook Luc Marengere, Managing Partner, TVM Capital Life Science

6.00pm Evening Reception at Hotel Sofitel Salon Paloma Picasso

Thank you for attending - looking forward to seeing you again next year and discussing the latest state of our industry!

Your TVM Capital Life Science Team